Amedisys Inc. (Nasdaq: AMED) saw hospice revenue-per-day and costs-per-day both rise during the second quarter of the year. The company released its Q2 results with no associated conference call. Amedisys is in the process of being acquired by the insurance giant UnitedHealth Group (NYSE: UNH), which has been gummed up by legal and regulatory hurdles. Amedisys saw its hospice revenue-per-day rise 4.1% in Q2, coupled with a 2.9% increase in cost-per-day. The company also saw a 0.4% increase in admissions and a 1.3% jump in average daily census.
Read the full article: Amedisys Sees Hospice Revenue Rise amid DOJ’s UnitedHealth Group Acquisition Lawsuit //
Source: https://hospicenews.com/2025/07/30/amedisys-sees-hospice-revenue-rise-amid-dojs-unitedhealth-group-acquisition-lawsuit/